COMPANIES›AMAREX CLINICAL RESEARCH, LLC
✓ Verified H1B Sponsor

AMAREX CLINICAL RESEARCH, LLC

Germantown, MDEIN 522138315
TRUST SCORE
87.6
High Trust
7
FY2024 H1B Approvals
7
All-time Approvals
87.6
Trust Score / 100

TOP SPONSORED JOB CATEGORIES

Database AdministratorsStatistical AssistantsBioinformatics Scientists

RECENT H1B FILINGS

JOB TITLELOCATIONWAGEDATE
Clinical Data ManagersGermantown, MD$96,876Oct 2025
Statistical AssistantsGermantown, MD$78,154.02Oct 2025
Statistical AssistantsGermantown, MD$70,000Oct 2025
StatisticiansGermantown, MD$111,488Sep 2025
Database AdministratorsGermantown, MD$85,000Oct 2024
Bioinformatics ScientistsGermantown, MD$138,630.39Oct 2024
Bioinformatics ScientistsGermantown, MD$138,630.39Oct 2024
Database AdministratorsGermantown, MD$85,000Oct 2024
Database AdministratorsGermantown, MD$85,000Oct 2024
Database AdministratorsGermantown, MD$85,000Oct 2024

SHOWING 50 MOST RECENT · SOURCE: DOL LCA PUBLIC DATA FY2024 · EIN 522138315

FREQUENTLY ASKED QUESTIONS

Does AMAREX CLINICAL RESEARCH, LLC sponsor H1B visas?

Yes. AMAREX CLINICAL RESEARCH, LLC has an active H1B sponsorship history with 7 total approved LCA filings on record, including 7 approvals in FY2024. Data sourced from US Department of Labor public disclosure files.

How many H1B visas has AMAREX CLINICAL RESEARCH, LLC sponsored?

According to DOL LCA data, AMAREX CLINICAL RESEARCH, LLC has 7 all-time H1B approvals and 7 approvals in fiscal year 2024.

What types of roles does AMAREX CLINICAL RESEARCH, LLC sponsor H1B for?

AMAREX CLINICAL RESEARCH, LLC most commonly sponsors H1B visas for: Database Administrators, Statistical Assistants, Bioinformatics Scientists. This is based on their DOL Labor Condition Application filing history.

Is AMAREX CLINICAL RESEARCH, LLC a reliable H1B sponsor?

AMAREX CLINICAL RESEARCH, LLC has a Trust Score of 87.6/100 on KEEL, calculated from total approval volume, recency of filings, and approval consistency based on DOL LCA data.

DATA SOURCE: US DEPT. OF LABOR · LCA PUBLIC DISCLOSURE FY2023–FY2024